Tetrapyrroles and derivatives
Abcam Clozapine N-o x ide, Metabolite of Clozapine, 25MG
MW 342.8 Da, Purity >99%. Metabolite of atypical antipsychotic Clozapine (ab120019). Active in vitro and in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam AT x -II, NaV channel activator, 100UG
MW 4941 Da, Purity >95%. ATX-II, NaV channel activator. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Clozapine N-o x ide, Metabolite of Clozapine, 5MG
MW 342.8 Da, Purity >99%. Metabolite of atypical antipsychotic Clozapine (ab120019). Active in vitro and in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam AT x -II, NaV channel activator, 50UG
MW 4941 Da, Purity >95%. ATX-II, NaV channel activator. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB-277011-A dihydrochloride, D3 antagonist, 5MG
MW 511.5 Da, Purity >98%. Potent, highly selective D3 receptor antagonist (pKi = 7.95 at hD3 receptors). Exhibits over 100-fold selectivity over D2 receptors. Blood-brain barrier (BBB) permeable. Diminishes nicotine, cocaine and alcohol self-administration. Interferes with mechanisms of drug-taking and reinstatement of drug-taking behaviours.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB-277011-A dihydrochloride, D3 antagonist, 25MG
MW 511.5 Da, Purity >98%. Potent, highly selective D3 receptor antagonist (pKi = 7.95 at hD3 receptors). Exhibits over 100-fold selectivity over D2 receptors. Blood-brain barrier (BBB) permeable. Diminishes nicotine, cocaine and alcohol self-administration. Interferes with mechanisms of drug-taking and reinstatement of drug-taking behaviours.
The product is subject to the following: Abcam Restricted Use Statement
Abcam PD 168568 dihydrochloride, D4 antagonist, 10MG
MW 422.4 g/mol, Purity >99%. Potent and selective D₄ antagonist (Ki = 8.8 nM at D₄, and 1842 nM at D₂). Inhibits amphetamine stimulated locomotor activity in vivo; orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Rotigotine hydrochloride, Dopamine receptor agonist, 50MG
MW 351.93 g/mol, Purity >99%. Dopamine receptor agonist. High affinity for D₁, D₂ and D₃ receptors (Ki values are 83, 13 and 0.71 nM, respectively). Shows significant affinity at α₂B and 5-HT₁A receptors (Ki values are 27 and 30 nM, respectively). Exhibits anti-Parkinsonian and antidepressant activity.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Necrostatin-1, necroptosis inhibitor, 50MG
MW 259.33 Da, Purity >99%. Potent, specific necroptosis inhibitor (EC₅₀ = 490 nM). Selective allosteric inhibitor of death domain receptor-associated adaptor kinase RIP1 in vitro (EC₅₀ = 182 nM). Caspase independent, programmed necrosis pathway.
The product is subject to the following: Abcam Restricted Use Statement
STEMCELL Technologies Methylcobalamin, Size: 100 mg
Methylcobalamin is a vitamin B12 analog and a coenzyme involved in homocysteine metabolism (Okada et al.). Methylcobalamin elevates the activities of ERK1/2 and AKT and improves nerve regeneration in rats (Okada et al.). This small molecule has therapeutic potential for treating nervous disorders (Okada et al.).DIFFERENTIATION· Promotes Schwann cell differentiation in vitro (Nishimoto et al.).DISEASE MODELING· Promotes neuronal survival in rats (Okada et al.).
eMolecules 3-Hydroxy-4-methyl-2(3H)-thiazolethione | 49762-08-5 | MFCD00077793 | 5g
Combi-Blocks, Inc. | 3-Hydroxy-4-methyl-2(3H)-thiazolethione | 5g | 603151825 | QA-9143 | 95.000 | 49762-08-5 | MFCD00077793 | 147.210 | C4H5NOS2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
![Chemscene ChemScene | 3-Oxobenzo[d]isothiazole-2(3H)-carbaldehyde 1,1-dioxide | 5G | CS-0106913 | 0.98 | 50978-45-5| MFCD23380208 | 211.2](https://assets.fishersci.com/TFS-Assets/CCG/product-images/CS-0106913.JPG-250.jpg)
Chemscene ChemScene | 3-Oxobenzo[d]isothiazole-2(3H)-carbaldehyde 1,1-dioxide | 5G | CS-0106913 | 0.98 | 50978-45-5| MFCD23380208 | 211.2
ChemScene | 3-Oxobenzo[d]isothiazole-2(3H)-carbaldehyde 1,1-dioxide | 5G | CS-0106913 | 0.98 | 50978-45-5| MFCD23380208 | 211.2
Sigma Aldrich Fine Chemicals Biosciences 5,10,15,20-Tetrakis(4-hydroxyphenyl)-21H,23H-porphine Dye content 95 % | 51094-17-8 | MFCD00191501 | 250MG
5,10,15,20-Tetrakis(4-hydroxyphenyl)-21H,23H-porphine Dye content 95 % | Mol Wt: 678.73 | 51094-17-8 | MFCD00191501 | 250MG
Abcam SB 243213 dihydrochloride, 5HT2C receptor antagonist, 10MG
MW 464.9 Da, Purity >99%. Potent, selective 5-HT2C receptor antagonist (Ki = 1 nM). Neurological agent. Active *in vivo* and *in vitro*.
The product is subject to the following: Abcam Restricted Use Statement